| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Renata Solimini, Maria Concetta Rotolo, Simona Pichini, Roberta Pacific. Neurological Disorders in Medical Use of Cannabis: An Update. CNS & neurological disorders drug targets. vol 16. issue 5. 2018-05-01. PMID:28412919. |
medical cannabis is increasingly used as a treatment or adjunct treatment with different levels of efficacy in several neurological disorders or related symptoms (such as multiple sclerosis, autism, parkinson and alzheimer disease, tourette's syndrome, huntington's disease, neuropathic pain, epilepsy, headache), as well as in other medical conditions (e.g. |
2018-05-01 |
2023-08-13 |
Not clear |
| Theodora Nelson, Yi Hui Liu, Kara S Bagot, Martin T Stei. Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions. Journal of developmental and behavioral pediatrics : JDBP. vol 38. issue 6. 2018-04-05. PMID:28622159. |
alex states that he uses marijuana to relieve his anxiety and does not understand why this is problematic as marijuana is now legal in his state.kevin is a 24-year-old adult man with diagnoses of autism spectrum disorder, mild intellectual disability, and schizoaffective disorder. |
2018-04-05 |
2023-08-13 |
Not clear |
| Theodora Nelson, Yi Hui Liu, Kara S Bagot, Martin T Stei. Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions. Journal of developmental and behavioral pediatrics : JDBP. vol 38. issue 6. 2018-04-05. PMID:28622159. |
his father hopes that the marijuana will allow kevin's other medications to be decreased or discontinued.linda is an 11-year-old girl with high-functioning autism spectrum disorder, anxiety, and adhd-inattentive subtype. |
2018-04-05 |
2023-08-13 |
Not clear |
| S Stringer, C C Minică, K J H Verweij, H Mbarek, M Bernard, J Derringer, K R van Eijk, J D Isen, A Loukola, D F Maciejewski, E Mihailov, P J van der Most, C Sánchez-Mora, L Roos, R Sherva, R Walters, J J Ware, A Abdellaoui, T B Bigdeli, S J T Branje, S A Brown, M Bruinenberg, M Casas, T Esko, I Garcia-Martinez, S D Gordon, J M Harris, C A Hartman, A K Henders, A C Heath, I B Hickie, M Hickman, C J Hopfer, J J Hottenga, A C Huizink, D E Irons, R S Kahn, T Korhonen, H R Kranzler, K Krauter, P A C van Lier, G H Lubke, P A F Madden, R Mägi, M K McGue, S E Medland, W H J Meeus, M B Miller, G W Montgomery, M G Nivard, I M Nolte, A J Oldehinkel, Z Pausova, B Qaiser, L Quaye, J A Ramos-Quiroga, V Richarte, R J Rose, J Shin, M C Stallings, A I Stiby, T L Wall, M J Wright, H M Koot, T Paus, J K Hewitt, M Ribasés, J Kaprio, M P Boks, H Snieder, T Spector, M R Munafò, A Metspalu, J Gelernter, D I Boomsma, W G Iacono, N G Martin, N A Gillespie, E M Derks, J M Vin. Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium. Translational psychiatry. vol 6. 2017-02-06. PMID:27023175. |
previous studies reported associations of ncam1 with cigarette smoking and other substance use, and those of cadm2 with body mass index, processing speed and autism disorders, which are phenotypes previously reported to be associated with cannabis use. |
2017-02-06 |
2023-08-13 |
human |
| Deepmala, John Slattery, Nihit Kumar, Leanna Delhey, Michael Berk, Olivia Dean, Charles Spielholz, Richard Fry. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neuroscience and biobehavioral reviews. vol 55. 2016-04-04. PMID:25957927. |
in this systematic review we find favorable evidence for the use of nac in several psychiatric and neurological disorders, particularly autism, alzheimer's disease, cocaine and cannabis addiction, bipolar disorder, depression, trichotillomania, nail biting, skin picking, obsessive-compulsive disorder, schizophrenia, drug-induced neuropathy and progressive myoclonic epilepsy. |
2016-04-04 |
2023-08-13 |
Not clear |
| Scott E Hadland, John R Knight, Sion K Harri. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice. Journal of developmental and behavioral pediatrics : JDBP. vol 36. issue 2. 2016-03-11. PMID:25650954. |
the review then discusses some of the proposed uses of cannabis in developmental and behavioral conditions, including attention-deficit hyperactivity disorder and autism spectrum disorder. |
2016-03-11 |
2023-08-13 |
Not clear |
| Michael Berk, Gin S Malhi, Laura J Gray, Olivia M Dea. The promise of N-acetylcysteine in neuropsychiatry. Trends in pharmacological sciences. vol 34. issue 3. 2013-09-20. PMID:23369637. |
this review summarises the areas where the mechanisms of action of nac overlap with known pathophysiological elements, and offers a précis of current literature regarding the use of nac in disorders including cocaine, cannabis, and smoking addictions, alzheimer's and parkinson's diseases, autism, compulsive and grooming disorders, schizophrenia, depression, and bipolar disorder. |
2013-09-20 |
2023-08-12 |
Not clear |
| K Blum, E R Braverman, J M Holder, J F Lubar, V J Monastra, D Miller, J O Lubar, T J Chen, D E Coming. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of psychoactive drugs. vol 32 Suppl. 2001-04-26. PMID:11280926. |
therefore lack of d2 receptors causes individuals to have a high risk for multiple addictive, impulsive and compulsive behavioral propensities, such as severe alcoholism, cocaine, heroin, marijuana and nicotine use, glucose bingeing, pathological gambling, sex addiction, adhd, tourette's syndrome, autism, chronic violence, posttraumatic stress disorder, schizoid/avoidant cluster, conduct disorder and antisocial behavior. |
2001-04-26 |
2023-08-12 |
Not clear |